Patient Support

Let's make your recovery easier

Whether you're preparing for surgery or already recovering at home, our team is here to help.

ACL Reconstruction: How Active Cryocompression Accelerates Return to Sport Reading Total Knee Arthroplasty: what cryocompression truly changes in post-operative recovery

Total Knee Arthroplasty: what cryocompression truly changes in post-operative recovery

Total Knee Arthroplasty: what cryocompression truly changes in post-operative recovery

efractory pain, persistent effusion, delayed mobilisation... The post-operative period following TKA remains a major clinical challenge. Recent data confirm that active cryocompression delivers measurable benefits that ice therapy alone cannot achieve, including during the home recovery phase.


KOLDE  ·  Reading time: 8 min  ·  Orthopaedic Surgeons · Physiotherapists · Sports Medicine Physicians


Total knee arthroplasty (TKA) is now one of the most commonly performed orthopaedic procedures worldwide. In the MENA region, the standardised prevalence of osteoarthritis, the primary indication for TKA, increased by +9.3% between 1990 and 2019, with the knee joint being the most frequently affected.1 Across Gulf Cooperation Council (GCC) countries specifically, a meta-analysis of over 24,000 participants identifies age, female sex and obesity as the main risk factors for a rapidly growing joint pathology.2 In the UAE, a 2024 study confirms that the population recognises joint replacement as the reference treatment for advanced knee osteoarthritis.3 The TKA market in the region is in structural expansion.

Yet despite excellent medium-term functional outcomes, the immediate post-operative phase remains a zone of clinical discomfort. Acute pain, joint effusion, arthrogenic muscle inhibition, restricted range of motion: phenomena that, if poorly managed, delay rehabilitation and prolong convalescence. The question is no longer whether cryotherapy is useful after TKA, the literature has established that, but which type, applied how, and above all where: home recovery represents the bulk of the post-operative journey, often left without an appropriate device.


+9,3%

Increase in knee osteoarthritis prevalence in the MENA region between 1990 and 2019

−25%

Reduction in morphine consumption over 2 weeks post-TKA with active cryocompression

+99m

Additional walking distance at Day 21 in the cryocompression group vs standard cryotherapy



Why TKA generates such an intense inflammatory response

Understanding the value of cryocompression requires revisiting the pathophysiology of surgical trauma. TKA combines several simultaneous tissue injuries: extensive incision, tourniquet application, bilateral bone resection and prosthetic cementing. The resulting vascular and inflammatory response is proportional to this intensity.

In the hours following surgery, three phenomena cascade and reinforce one another. Haemarthrosis, the accumulation of blood in the joint cavity, generates painful capsular distension and reflexively inhibits quadriceps contraction, a mechanism known as arthrogenic muscle inhibition.6 Peri-articular oedema, driven by increased capillary permeability and lymphatic stasis, worsens tissue compression and reduces passive mobility. Finally, nociceptive pain, fuelled by the release of prostaglandins and inflammatory mediators, limits the patient's active participation in rehabilitation.

This triad, effusion, oedema and pain, forms a vicious cycle that pharmacological protocols alone cannot break. This is precisely where active cryocompression intervenes.


The majority of post-TKA recovery takes place at home. This is where the quality of the first degrees of flexion regained, the speed of oedema resorption and the patient's engagement in rehabilitation are truly decided. Prescribing cryocompression means extending care beyond the clinic walls.


Mechanisms of action: three distinct effects, one simultaneous action

The Game Ready® GRPro 2.1 system acts simultaneously on three complementary physiological dimensions, where traditional ice therapy targets only one.


CRYOTHERAPY

Pain control without opioids

Continuous cold at 4°C slows nociceptive fibre conduction and reduces local metabolism, limiting secondary necrosis and the release of pro-inflammatory mediators, without systemic effects.

COMPRESSION

Active oedema resorption

Intermittent pneumatic compression (5 to 75 mmHg) stimulates venous return, activates lymphatic circulation and reduces peri-articular fluid accumulation, a result impossible to achieve with a simple ice pack.

SYNERGIE

Improved mobility

The combination of cold and compression more rapidly lifts the arthrogenic muscle inhibition caused by effusion, enabling earlier quadriceps activation and accelerated recovery of joint range of motion from the very first days.





What the research shows — Study 1

In 2024, Quesnot et al. published in BMC Musculoskeletal Disorders the first randomised controlled trial directly comparing active cryocompression (CC, cryotherapy with dynamic compression via the Game Ready®) against standard cryotherapy (SC, ice packs with elastic bandaging) over 21 days of post-TKA rehabilitation.5 The study was conducted at the Clinique de la Porte Verte in Versailles, France.


RCT  Compressive cryotherapy vs standard cryotherapy after total knee arthroplasty

Quesnot A. et al. — BMC Musculoskeletal Disorders, 2024 · Clinique de la Porte Verte, Versailles (France)

40 patients

Randomised, 20 per group, over 21 days of post-TKA rehabilitation p = 0,002

Significant reduction in joint effusion in the cryocompression group at Day 21

439m vs 340m

Distance au test de marche 6 min à J21, groupe CC vs CS (p = 0,018) KOOS : 12 vs 24

KOOS score (Knee Injury and Osteoarthritis Outcome Score, standardised measure of pain, symptoms and functional independence). A lower score = better independence. Significantly better in the CC group (p = 0.004).

Key findings: Survival analysis shows that the cryocompression group reached the functional thresholds for passive flexion (90° for normal walking, 110° for stair descent) significantly faster (p = 0.011 and p = 0.038). Activity pain was also significantly lower in the CC group at Day 21 (p = 0.005). No adverse effects related to the Game Ready® device were reported.



These results are particularly meaningful for the clinician: the goal is not merely to reduce pain in the recovery room, but to enable the patient to reach the functional thresholds that determine their home independence more quickly. A walking distance 99 metres greater at Day 21, functional range of motion achieved earlier: these are tangible markers that the surgeon, physiotherapist and patient perceive directly in their daily convalescence.